| http://www.w3.org/ns/prov#value | - tal therapeutic alternative for the treatment of the erythrodermal phase of CTCL and cGvHD in allogenic HPTC and that this therapy should be evaluated in the framework of a RCT.Quality of life (Lansky/Karnofsky play performance score) was reported in 1 study.The patients in the studies were all refractory to steroids and other immunosuppressive agents, and these drugs were frequently continued con
|
